City Holding CO Haleon PLC Transaction History

City Holding CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 12, 2024	SELL	$8.01 - $8.64 $5,206 - $5,616	-650 Reduced 27.48%	1,715 $14,000
Q4 2023 Jan 10, 2024	SELL	$7.78 - $8.62 $575 - $637	-74 Reduced 3.03%	2,365 $19,000
Q3 2023 Oct 13, 2023	SELL	$7.85 - $8.94 $588 - $670	-75 Reduced 2.98%	2,439 $20,000
Q2 2023 Jul 13, 2023	SELL	$8.04 - $9.0 $17,406 - $19,485	-2,165 Reduced 46.27%	2,514 $21,000
Q1 2023 Apr 17, 2023	SELL	$7.57 - $8.37 $757 - $836	-100 Reduced 2.09%	4,679 $38,000
Q4 2022 Jan 27, 2023	SELL	$5.96 - $8.06 $4,321 - $5,843	-725 Reduced 13.17%	4,779 $0
Q3 2022 Oct 12, 2022	BUY	$5.63 - $7.5 $30,987 - $41,280	5,504 New	5,504 $34,000

639

412M

149K

16K

Ticker HLN
Exchange
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 4,617,290,240
Market Cap $44.8B
Description
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...

Get notified when there are updates to the investment portfolio of City Holding CO, based on Form 13F filings with the SEC.

Stay updated on City Holding CO with notifications on news.